Inpegsomatropin is under clinical development by Xiamen Amoytop Biotech and currently in Phase II for Turner Syndrome.

Human papillomavirus (9-valent) vaccine is under clinical development by Xiamen Innovax Biotech and currently in Phase II for Human Papillomavirus Infections.

China is the world's top fish consumer and is spending billions on technology designed to restock the oceans. But will this ...

China’s Mainland Affairs Council (MAC) said they will investigate claims made in a YouTube video about China’s efforts to ...

Taiwan's Mainland Affairs Council is investigating claims from a video alleging China's political influence on young ...

Lichen China Limited (Nasdaq: LICN) ("Lichen China" or the "Company"), a dedicated financial and taxation service provider in China today announced that it has entered into a definitive agreement with ...

We are excited to bring The Ritz-Carlton to Xiamen, offering guests the opportunity to indulge in our legendary luxury ...

Penang’s tourism sector is thriving, with China remaining one of its top international visitor sources in 2024.

International announced the signing of an agreement with Xiamen Green Development Investment Group to introduce The ...

In July, China unveiled a landmark resolution to set the stage for a new phase of reform aimed at advancing Chinese modernization. With a focus on the next five years, the blueprint outlines over 300 ...

Marriott International, Inc. today announced the signing of an agreement with Xiamen Green Development Investment Group to ...

By consolidating these essential treatments into one daily dose, the polypill simplifies the management of complex health ...